NCT06732388 2026-03-18
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
National Cancer Institute (NCI)
Phase 2 Not yet recruiting
Clinical Trials
28 trialsNCT00712712 2025-08-29
MEDOR
Institut Bergonié
Phase 2 Completed
NCT07095803 2025-07-31
Ivonescimab (PD-1/VEGF Bispecific Antibody) Plus Radiofrequency Ablation for Multiple Advanced Tumors After PD-1 Therapy Failure
Fudan University
Phase 2 Not yet recruiting
NCT03753659 2024-07-22
IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Completed
NCT04698252 2022-08-08
LARA
Instituto do Cancer do Estado de São Paulo
Phase 2 Recruiting
NCT05485909 2022-08-03
Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM
Sun Yat-sen University
Phase 2 Unknown
NCT03101475 2022-05-31
ILOC
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00029029 2020-08-12
Radiofrequency Ablation in Relieving Pain in Patients With Bones Metastases
Mayo Clinic
Phase 2 Completed
NCT00024076 2020-08-03
Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Completed
NCT04150744 2020-07-08
RFA Plus Carrizumab vs Carrizumab Alone for HCC
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
NCT03750396 2019-02-15
CLEAR
Gangnam Severance Hospital
Phase 2 Unknown
NCT00004136 2018-11-06
Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00004142 2018-10-26
Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01986829 2018-09-19
Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy
Washington University School of Medicine
Phase 2 Terminated
NCT00373152 2017-12-05
MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer
Masonic Cancer Center, University of Minnesota
Phase 2 Withdrawn
NCT00408772 2017-06-09
Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer
University of California, Davis
Phase 2 Withdrawn
NCT00030563 2017-04-17
Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver
University of Washington
Phase 2 Completed
NCT00019604 2017-02-03
Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT00922948 2016-07-27
Cryoablation Versus Radiofrequency Ablation for Small Renal Masses
St. Joseph's Healthcare Hamilton
Phase 2 Withdrawn
NCT02468076 2016-05-11
IGNITE-1
Universitaire Ziekenhuizen KU Leuven
Phase 2 Completed
NCT02487693 2016-02-23
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma
The First People's Hospital of Changzhou
Phase 2 Active not recruiting
NCT02490748 2016-02-23
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer
The First People's Hospital of Changzhou
Phase 2 Active not recruiting
NCT02634502 2015-12-18
Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis
Fudan University
Phase 2 Unknown
NCT00019955 2015-04-29
Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)
National Cancer Institute (NCI)
Phase 2 Completed
NCT00043004 2012-09-24
Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated
NCT00039507 2010-02-12
Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer
Fox Chase Cancer Center
Phase 2 Completed
NCT00868647 2009-09-01
Radiofrequency Ablation (RFA) Of Tumors Acquired In Childhood
Seattle Children's Hospital
Phase 2 Suspended
NCT00180856 2005-09-16
Radiofrequency Ablation of Lung Tumors
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Completed